Novel medicines hold promise for patients, but rising costs pose affordability and equity challenges for health systems ...
The renewed debate over Most Favored Nation (MFN) drug pricing in the United States reflects a legitimate frustration: ...
Initial numbers show marketplace sign-ups down by more than 1 million people nationwide in 2026, with enrollment expected to ...
The U.S. spends far more on health care than other wealthy nations, but that investment does not achieve better quality of care or improved health outcomes . Furthermore, both spending and quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results